Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic Neuropathy

Update Il y a 4 ans
Reference: NCT00496457

Woman and Man

Extract

The purpose of this study is to assess the efficacy and safety of TRO19622 administered PO daily for 6 weeks compared to placebo administered PO daily in patients with painful peripheral diabetic neuropathy.


Inclusion criteria

  • Diabetic Neuropathy


Links